The GABAB receptor agonist, baclofen, contributes to three distinct varieties of amnesia in the human brain

Publication date: Available online 26 October 2015
Source:Cortex
Author(s): Adam Zeman, Serge Hoefeijzers, Fraser Milton, Michaela Dewar, Melanie Carr, Claire Streatfield
We describe a patient in whom long-term, therapeutic infusion of the selective gamma-amino-butyric acid type B (GABAB) receptor agonist, baclofen, into the cerebrospinal fluid gave rise to three distinct varieties of memory impairment: i) repeated, short periods of severe global amnesia, ii) accelerated long-term forgetting, evident over intervals of days and iii) a loss of established autobiographical memories. This pattern of impairment has been reported in patients with temporal lobe epilepsy, in particular the subtype of Transient Epileptic Amnesia. The amnesic episodes and accelerated forgetting remitted on withdrawal of baclofen, while the autobiographical amnesia persisted. This exceptional case highlights the occurrence of 'non-standard' forms of human amnesia, reflecting the biological complexity of memory processes. It suggests a role for GABAB signalling in the modulation of human memory over multiple time-scales and hints at its involvement in 'epileptic amnesia'.



from #Medicine via ola Kala on Inoreader http://ift.tt/1P2U8zK
via IFTTT